PHILADELPHIA—Earlier today, the U.S. FDA issued marketing denial orders to Juul Labs, Inc. which means that the company is no longer allowed to sell or distribute these products in the United States. In 2020, the City filed a lawsuit against Juul Labs, Inc. alleging the company’s role in cultivating and fostering an e-cigarette epidemic among youth in Philadelphia. The Philadelphia Department of Public Health issued the following statement after the FDA’s action.

“The Food and Drug Administration’s (FDA) decision to remove JUUL from the marketplace is an important step forward in protecting our youth and young adults from the serious harms of tobacco use and nicotine addiction,” said Tobacco Control Program Manager Ryan Coffman. “JUUL is widely acknowledged for its central role in igniting a nationwide youth vaping epidemic that we are still experiencing today. The Philadelphia Department of Public Health strongly urges the FDA to promptly complete the overdue review of all received e-cigarette marketing applications and, where appropriate, to similarly remove other e-cigarette brands that have co-opted JUUL’s technology and their use of youth-oriented flavors and marketing strategies. Any young person or adult that is trying to quit vaping can visit This is Quitting or call the PA Free Quitline at 1-800-Quit-Now.”